Zhou Q, Meng X, Sun L, Huang D, et al. Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study. J Thorac Oncol 2024 Aug 8:S1556-0864(24)00762.
PMID: 39127176